Gardiner Healthcare Acquisitions Corp. Announces Extension

Furthermore, the Company received notice from the Gardiner Sponsor that the Gardiner Sponsor intends to deposit funds into the trust account under the Trus...

April 22, 2023 | Saturday | News
Genmab Announces Initial Resolution of Its Second Arbitration Under License Agreement with Janssen

One of the three arbitrators dissented. Genmab has the right to seek review of the award, which it must do within a limited period of time. Genmab is curre...

April 21, 2023 | Friday | News
Aptitude gets up to $54M from BARDA to Develop At-Home Diagnostics.

Aptitude Medical Systems (Aptitude™) announced today that it has received an award up to $53.7 million from Biomedical Advanced Research and Developm...

April 21, 2023 | Friday | News
Roquette unveils its $25 million Pharmaceutical Innovation Center in the United States.

Roquette, a global leader  in plant-based ingredients and a leading provider of pharmaceutical and nutraceutical  excipients, today celebrates th...

April 20, 2023 | Thursday | News
Foundational LCD Covers Select mdx for Prostate Cancer

Michael K. McGarrity, CEO of mdxhealth, commented: “We are pleased to report this very positive and important development for mdxhealth. The quality ...

April 20, 2023 | Thursday | News
Daewoong Pharmaceutical and Sygnature Discovery announce drug discovery research collaboration

Daewoong Pharmaceutical has entered a research collaboration with Sygnature Discovery to expand its global open innovation for novel drug development. On ...

April 19, 2023 | Wednesday | News
Otsuka and Lundbeck's Statement on FDA Advisory Committee Meeting for REXULTI in Alzheimer's Agitation

Otsuka Pharmaceutical Development & Commercialization, Inc., (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck) announce the Joint Meeting of the Psy...

April 18, 2023 | Tuesday | News
TORL BioTherapeutics Launches with $158M to Develop Novel Oncology Biologics

Co-founded by acclaimed oncologist Dennis Slamon, M.D., Ph.D., of University of California at Los Angeles (UCLA) and entrepreneur and CEO David Licata, a...

April 17, 2023 | Monday | News
Caris Life Sciences and Flare Therapeutics Form Partnership for Precision Oncology Pipeline

The partnership reinforces Flare's commitment to longitudinal testing, leveraging Caris' comprehensive molecular tissue and liquid profiling services inclu...

April 17, 2023 | Monday | News
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.

PRA023 is a novel, late-stage candidate for ulcerative colitis and Crohn’s disease and other autoimmune conditions   Prometheus Biosciences&rs...

April 17, 2023 | Monday | News
Aspect Biosystems, Novo Nordisk partner to bioprint tissue therapies for diabetes, obesity.

Partnership will leverage Aspect’s proprietary bioprinting technology and Novo Nordisk’s expertise and technology in stem cell differentiation ...

April 14, 2023 | Friday | News
Ocutrx Acquires 25 Year FDA & Hi-Reliability Manufacturing Company to Advance Capabilities for Medical Devices

Ocutrx Technologies, a global technology company developing revolutionary medical devices with augmented reality (AR), extended reality (XR) and artificial...

April 13, 2023 | Thursday | News
Araris Biotech AG Announces Strategic Investment with Samsung Ventures

Samsung Ventures makes investment in Araris Proceeds will be used to support further development and advancement of Araris’ antibody-drug conjugat...

April 12, 2023 | Wednesday | News
First Avenue Ventures Fund I invests in Diamond Therapeutics for Mental Health Innovation

Proceeds from the fund's investment will support Diamond's collaboration with UAB on an investigator-led clinical trial of low-dose psilocybin to treat dem...

April 10, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close